European Innovation Council

The EIC pilot supports top-class innovators, entrepreneurs, small companies and scientists with bright ideas and the ambition to scale up internationally. It brings together the parts of Horizon 2020 that provide funding, advice and networking opportunities for those at cutting edge of innovation.

David Malo Jean

Director

Past deals in Genetics

Ovagen

Grant in 2022
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry & rodent research technologies to GMP standards and in avian transgenics.

Genetika+

Grant in 2022
Genetika+ is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.

Ovagen

Grant in 2022
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry & rodent research technologies to GMP standards and in avian transgenics.

Core Biogenesis

Venture Round in 2022
Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies. The company uses proprietary gene editing and plant biotechnology to drastically reduce the cost of making growth factors. The growth factors are molecules used in the clean meat and cell therapy industries.

SwissDeCode

Grant in 2021
SwissDeCode Sàrl, founded in 2016 and based in Renens, Switzerland, specializes in providing rapid on-site DNA testing solutions for the food industry. The company focuses on ensuring food safety and authenticity by offering plug-and-play testing services that allow food manufacturers to receive quality and safety certifications within the same work shift. This capability enables immediate decision-making regarding food authenticity and compliance, helping to transform potential contamination risks into sustainable opportunities for producers. By validating the integrity of the food supply chain, SwissDeCode supports food manufacturers in delivering safe and reliable products to consumers.

enGenome

Grant in 2021
enGenome is a bioinformatics company provides accurate omics-based reports to physicians, thus improving diagnosis and treatment processes for patients. Their products and services helps to improve the diagnosis of genetic diseases and patients therapies by producing accurate genetic reports.

Genome Biologics

Grant in 2021
Genome Biologics are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses where no other treatments have proven effective or ever existed.

Epigene Labs

Venture Round in 2021
Epigene Labs SAS, founded in 2019 and headquartered in Paris, France, with an additional office in Boston, Massachusetts, develops a biotechnology platform that harnesses advanced artificial intelligence to transform genomic data into actionable insights for precision oncology. The platform addresses the challenges of aggregating, analyzing, and visualizing extensive genomic datasets, which are crucial for advancing precision oncology. By integrating proprietary data from partners with publicly available information, Epigene Labs provides medical researchers with user-friendly analytics and insights that facilitate drug development and research in cancer treatment. The company focuses on forming value-based partnerships with leading cancer centers and prominent biotech firms to enhance the efficacy of oncology solutions.

Sequentia Biotech

Grant in 2021
Sequentia Biotech, founded in 2013 by Walter Sanseverino and Riccardo Aiese Cigliano, is a bioinformatics company based at the UAB Research Park. The company specializes in transforming genomic data into actionable insights for various sectors, including academic research, plant and animal breeding, and biomedicine. Sequentia collaborates with over 30 public and private research centers, universities, and companies, participating in more than 160 research and development projects. The company offers a range of services, including cloud software, custom software solutions, and bioinformatics consulting, aimed at advancing healthcare, agriculture, and environmental sciences. Sequentia Biotech also maintains two open-source biodata banks and has developed an award-winning research initiative called Tricopharming. The founders have contributed significantly to the field, with over 40 scientific publications in prestigious journals.

Sequentia Biotech

Venture Round in 2021
Sequentia Biotech, founded in 2013 by Walter Sanseverino and Riccardo Aiese Cigliano, is a bioinformatics company based at the UAB Research Park. The company specializes in transforming genomic data into actionable insights for various sectors, including academic research, plant and animal breeding, and biomedicine. Sequentia collaborates with over 30 public and private research centers, universities, and companies, participating in more than 160 research and development projects. The company offers a range of services, including cloud software, custom software solutions, and bioinformatics consulting, aimed at advancing healthcare, agriculture, and environmental sciences. Sequentia Biotech also maintains two open-source biodata banks and has developed an award-winning research initiative called Tricopharming. The founders have contributed significantly to the field, with over 40 scientific publications in prestigious journals.

SwissDeCode

Grant in 2020
SwissDeCode Sàrl, founded in 2016 and based in Renens, Switzerland, specializes in providing rapid on-site DNA testing solutions for the food industry. The company focuses on ensuring food safety and authenticity by offering plug-and-play testing services that allow food manufacturers to receive quality and safety certifications within the same work shift. This capability enables immediate decision-making regarding food authenticity and compliance, helping to transform potential contamination risks into sustainable opportunities for producers. By validating the integrity of the food supply chain, SwissDeCode supports food manufacturers in delivering safe and reliable products to consumers.

SwissDeCode

Venture Round in 2020
SwissDeCode Sàrl, founded in 2016 and based in Renens, Switzerland, specializes in providing rapid on-site DNA testing solutions for the food industry. The company focuses on ensuring food safety and authenticity by offering plug-and-play testing services that allow food manufacturers to receive quality and safety certifications within the same work shift. This capability enables immediate decision-making regarding food authenticity and compliance, helping to transform potential contamination risks into sustainable opportunities for producers. By validating the integrity of the food supply chain, SwissDeCode supports food manufacturers in delivering safe and reliable products to consumers.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.